Plasma lactate and incident hypertension in the atherosclerosis risk in communities study

American Journal of Hypertension

Volumn 28, Issue 2, 2015, Pages 216-224

  Juraschek, Stephen P ^a,b,c   Bower, Julie K ^b   Selvin, Elizabeth ^a,b,c   Shantha, Ghanshyam Palamaner Subash ^b   Hoogeveen, Ron C ^d,e   Ballantyne, Christie M ^d,e   Hunter Young, J ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

ARIC; blood pressure; cohort; hypertension; lactate

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LACTIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; BLACK PERSON; CARDIOVASCULAR RISK; COHORT ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG USE; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PREHYPERTENSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF REPORT; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; AGED; BLOOD; INCIDENCE; LONGITUDINAL STUDY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL;

AGED; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; LACTIC ACID; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 84922507369     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpu117     Document Type: Article

References (40)

1. Centers for Disease Control. National Ambulatory Medical Care Survey: 2008. http://www.cdc.gov/nchs/fastats/docvisit.htm.
2. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010; 303:2043-2050.
3. Crawford S O, Ambrose MS, Hoogeveen RC, Brancati FL, Ballantyne CM, Young JH. Association of lactate with blood pressure before and afer rapid weight loss. Am J Hypertens 2008; 21:1337-1342.
4. Zagari F, Jordan M, Stettler M, Broly H, Wurm FM. Lactate metabolism shif in CHO cell culture: the role of mitochondrial oxidative activity. N Biotechnol 2013; 30:238-245.
5. DiGirolamo M, Newby FD, Lovejoy J. Lactate production in adipose tissue: a regulated function with extra-adipose implications. FASEB J 1992; 6:2405-2412.
6. Doar J W, Wynn V, Cramp DG. Blood pyruvate and plasma glucose levels during oral and intravenous glucose tolerance tests in obese and non-obese women. Metab Clin Exp 1968; 17:690-701.
7. Baron AD, Brechtel-Hook G, Johnson A, Hardin D. Skeletal muscle blood fow. A possible link between insulin resistance and blood pressure. Hypertension 1993; 21:129-135.
8. Jansson PA, Larsson A, Lönnroth PN. Relationship between blood pressure, metabolic variables and blood fow in obese subjects with or without non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1998; 28:813-818.
9. National Heart Lung and Blood Institute. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure-Complete Report. http://www.nhlbi. nih.gov/guidelines/hypertension/jnc7full.pdf.
10. Barham D, Trinder P. An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst 1972; 97:142-145.
11. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G. Atherosclerosis Risk in Communities Study. Low-grade systemic infammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003; 52:1799-1805.
12. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Ofenbacher S, Azambuja MI, Tracy RP, Heiss G. Markers of infamma-tion and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 1999; 353:1649-1652.
13. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982; 36:936-942.
14. Mizock BA, Falk JL. Lactic acidosis in critical illness. Crit Care Med. 1992; 20:80-93.
15. Wagenknecht L, Wasserman B, Chambless L, Coresh J, Folsom A, Mosley T, Ballantyne C, Sharrett R, Boerwinkle E. Correlates of carotid plaque presence and composition as measured by MRI: the Atherosclerosis Risk in Communities Study. Circ Cardiovasc Imaging 2009; 2:314-322.
16. Iannello S, Campione R, Belfore F. Response of insulin, glucagon, lac-tate, and nonesterifed fatty acids to glucose in visceral obesity with and without NIDDM: relationship to hypertension. Mol Genet Metab 1998; 63:214-223.
17. Astles R, Williams C P, Sedor F. Stability of plasma lactate in vitro in the presence of antiglycolytic agents. Clin Chem 1994; 40:1327-1330.
18. Dubé M P, Kitch D W, Parker RA, Alston-Smith BL, Mulligan K. The efect of long-term storage on measured plasma lactate concentrations and prospective lactate results from a multicenter trial of antiretroviral therapy. Clin Chem Lab Med 2005; 43:947-952.
19. Praet SFE, Jonkers RA, Schep G, Stehouwer CD, Kuipers H, Keizer HA, van Loon LJ. Long-standing, insulin-treated type 2 diabetes patients with complications respond well to short-term resistance and interval exercise training. Eur J Endocrinol 2008; 158:163-172.
20. Cocks M, Shaw CS, Shepherd SO, Fisher JP, Ranasinghe AM, Barker TA, Tipton KD, Wagenmakers AJ. Sprint interval and endurance training are equally efective in increasing muscle microvascular density and eNOS content in sedentary males. J Physiol (Lond) 2013; 591:641-656.
21. Meredith CN, Frontera WR, Fisher EC, Hughes VA, Herland JC, Edwards J, Evans WJ. Peripheral efects of endurance training in young and old subjects. J Appl Physiol 1989; 66:2844-2849.
22. Crawford MH. Physiologic consequences of systematic training. Cardiol Clin 1992; 10:209-218.
23. Fernandes T, Nakamuta JS, Magalhães FC, Roque FR, Lavini-Ramos C, Schettert IT, Coelho V, Krieger JE, Oliveira EM. Exercise training restores the endothelial progenitor cells number and function in hypertension: implications for angiogenesis. J Hypertens 2012; 30:2133-2143.
24. Bassett DR Jr. Skeletal muscle characteristics: relationships to cardiovascular risk factors. Med Sci Sports Exerc 1994; 26:957-966.
25. El-Atat F, Aneja A, Mcfarlane S, Sowers J. Obesity and hypertension. Endocrinol Metab Clin North Am 2003; 32:823-854.
26. Regazzetti C, Peraldi P, Grémeaux T, Najem-Lendom R, Ben-Sahra I, Cormont M, Bost F, Le Marchand-Brustel Y, Tanti JF, Giorgetti-Peraldi S. Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes 2003; 58:95-103.
27. Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, Furukawa S, Tochino Y, Komuro R, Matsuda M, Shimomura I. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregula-tion. Diabetes 2007; 56:901-911.
28. Padmanabhan S, Newton-Cheh C, Dominiczak AF. Genetic basis of blood pressure and hypertension. Trends Genet 2012; 28:397-408.
29. Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, Shah PK, Willerson JT, Benza RL, Berman DS, Gibson CM, Bajamonde A, Rundle AC, Fine J, McCluskey ER. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 2003; 107:1359-1365.
30. Lankhorst S, Kappers MHW, van Esch JHM, Danser AHJ, van den Meiracker AH. Mechanism of hypertension and proteinuria during angiogenesis inhibition: evolving role of endothelin-1. J Hypertens 2013; 31:444-454.
31. Sharrett AR, Hubbard LD, Cooper LS, Sorlie PD, Brothers RJ, Nieto FJ, Pinsky JL, Klein R. Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 1999; 150:263-270.
32. Struijker Boudier HA, le Noble JL, Messing M W, Huijberts MS, le Noble FA, van Essen H. The microcirculation and hypertension. J Hypertens Suppl 1992; 10:S147-156.
33. Sullivan JM, Prewitt RL, Josephs JA. Attenuation of the microcircu-lation in young patients with high-output borderline hypertension. Hypertension 1983; 5:844-851.
34. Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, Watt GC. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 1997; 99:1873-1879.
35. Daugherty SL, Masoudi FA, Zeng C, Ho PM, Margolis KL, O'Connor PJ, Go AS, Magid DJ. Sex diferences in cardiovascular outcomes in patients with incident hypertension. J Hypertens 2013; 31:271-277.
36. Staessen JA, Ginocchio G, Tijs L, Fagard, R. Conventional and ambulatory blood pressure and menopause in a prospective population study. J Hum Hypertens 1997; 11:507-514.
37. Lötscher F, Löfel T, Steiner R, Vogt M, Klossner S, Popp A, Lippuner K, Hoppeler H, Däpp C. Biologically relevant sex diferences for ftness-related parameters in active octogenarians. Eur J Appl Physiol 2007; 99:533-540.
38. Gigli I, Bussmann LE. Exercise and ovarian steroid hormones: their efects on mitochondrial respiration. Life Sci 2001; 68:1505-1514.
39. Schneider ALC, Pankow JS, Heiss G, Selvin E. Validity and reliability of self-reported diabetes in the atherosclerosis risk in communities study. Am J Epidemiol 2012; 176:738-743.
40. Selem SS, Castro, MA, César CLG, Marchioni DML, Fisberg RM. Validity of self-reported hypertension is inversely associated with the level of education in Brazilian individuals. Arq Bras Cardiol 2013; 100:52-59.